Wanbangde Pharmaceutical Holding Group Co Ltd (002082) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.04 Million ≈ $-151.51K USD) by net assets (CN¥2.77 Billion ≈ $404.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Wanbangde Pharmaceutical Holding Group C fund operations to measure how many days the company can operate on defensive assets alone.

Wanbangde Pharmaceutical Holding Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wanbangde Pharmaceutical Holding Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Array Technologies Inc NASDAQ:ARRY	0.068x
Chang Wah Electromaterials Inc TW:8070	0.037x
Jiangsu Wujiang Rural Coml Bk SHG:603323	-0.276x
Shanghai Prisemi Electronics Co Ltd SHG:688230	0.012x
Clear Channel Outdoor Holdings Inc NYSE:CCO	-0.001x
GuangZhou BaiYun Elec Equip Co SHG:603861	-0.017x
U-Haul Holding Company NYSE:UHAL	0.031x
Jiangsu Shagang Co Ltd SHE:002075	0.072x

Annual Cash Flow Conversion Efficiency for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Wanbangde Pharmaceutical Holding Group C market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.61 Billion ≈ $381.57 Million	CN¥603.98 Million ≈ $88.38 Million	0.232x	+431.07%
2024-12-31	CN¥2.76 Billion ≈ $403.35 Million	CN¥120.22 Million ≈ $17.59 Million	0.044x	+265.13%
2023-12-31	CN¥2.76 Billion ≈ $403.72 Million	CN¥-72.87 Million ≈ $-10.66 Million	-0.026x	+68.93%
2022-12-31	CN¥2.82 Billion ≈ $412.52 Million	CN¥-239.65 Million ≈ $-35.07 Million	-0.085x	-1156.46%
2021-12-31	CN¥2.74 Billion ≈ $401.63 Million	CN¥22.09 Million ≈ $3.23 Million	0.008x	-84.77%
2020-12-31	CN¥2.86 Billion ≈ $418.23 Million	CN¥151.01 Million ≈ $22.10 Million	0.053x	+140.62%
2019-12-31	CN¥1.91 Billion ≈ $279.76 Million	CN¥-248.69 Million ≈ $-36.39 Million	-0.130x	-265.60%
2018-12-31	CN¥1.72 Billion ≈ $252.22 Million	CN¥135.40 Million ≈ $19.81 Million	0.079x	+815.48%
2017-12-31	CN¥1.60 Billion ≈ $234.64 Million	CN¥-17.60 Million ≈ $-2.58 Million	-0.011x	-104.93%
2016-12-31	CN¥1.40 Billion ≈ $204.36 Million	CN¥310.71 Million ≈ $45.47 Million	0.222x	+1687.76%
2015-12-31	CN¥1.35 Billion ≈ $197.11 Million	CN¥16.76 Million ≈ $2.45 Million	0.012x	-88.50%
2014-12-31	CN¥1.30 Billion ≈ $189.69 Million	CN¥140.31 Million ≈ $20.53 Million	0.108x	-45.14%
2013-12-31	CN¥1.19 Billion ≈ $173.83 Million	CN¥234.35 Million ≈ $34.29 Million	0.197x	+6.79%
2012-12-31	CN¥1.10 Billion ≈ $160.59 Million	CN¥202.73 Million ≈ $29.67 Million	0.185x	+13651.98%
2011-12-31	CN¥1.05 Billion ≈ $154.24 Million	CN¥-1.44 Million ≈ $-210.26K	-0.001x	-100.79%
2010-12-31	CN¥936.13 Million ≈ $136.98 Million	CN¥162.26 Million ≈ $23.74 Million	0.173x	+106.47%
2009-12-31	CN¥811.59 Million ≈ $118.76 Million	CN¥68.13 Million ≈ $9.97 Million	0.084x	-76.37%
2008-12-31	CN¥712.31 Million ≈ $104.23 Million	CN¥253.06 Million ≈ $37.03 Million	0.355x	+1084.23%
2007-12-31	CN¥415.12 Million ≈ $60.74 Million	CN¥12.45 Million ≈ $1.82 Million	0.030x	+206.57%
2006-12-31	CN¥357.72 Million ≈ $52.35 Million	CN¥3.50 Million ≈ $512.24K	0.010x	-86.67%
2005-12-31	CN¥152.88 Million ≈ $22.37 Million	CN¥11.23 Million ≈ $1.64 Million	0.073x	-69.41%
2004-12-31	CN¥136.17 Million ≈ $19.93 Million	CN¥32.69 Million ≈ $4.78 Million	0.240x	-36.09%
2003-12-31	CN¥98.53 Million ≈ $14.42 Million	CN¥37.01 Million ≈ $5.42 Million	0.376x	--

About Wanbangde Pharmaceutical Holding Group Co Ltd

SHE:002082 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.22 Billion

CN¥8.35 Billion CNY

Market Cap Rank

#8212 Global

#1988 in China

Share Price

CN¥13.65

Change (1 day)

-0.22%

52-Week Range

CN¥6.60 - CN¥36.24

All Time High

CN¥36.24